Evaluating Muscle Weakness Improvement With Lorcaserin in ICU

Summary

ICU acquired muscle weakness is a significant problem in patients recovering from critical illness. This trial will evaluate the safety and efficacy of a drug in improving muscle weakness in critically ill patients.

Timeline

Start

2015-12

Primary completion

2017-12

Completion

2017-12

Drugs

Indications